Chemistry: analytical and immunological testing – Heterocyclic carbon compound – Hetero-o
Reexamination Certificate
2011-07-12
2011-07-12
Wallenhorst, Maureen M (Department: 1777)
Chemistry: analytical and immunological testing
Heterocyclic carbon compound
Hetero-o
C436S063000, C436S161000, C436S173000, C436S901000, C250S281000, C250S282000
Reexamination Certificate
active
07977107
ABSTRACT:
A method for confirming the active intake of marijuana and its active component Δ9-tetrahydrocannabinol (“Δ9-THC”) by detecting the amount of 11-nor-Δ9-THC carboxylic acid (“THCA”) in oral fluid at the picogram per milliliter (pg/ml) level using chromatography/mass spectrometry/mass spectrometry (“GC/MS/MS”).
REFERENCES:
patent: 4921788 (1990-05-01), Deutsch
patent: 5036014 (1991-07-01), Elsohly et al.
patent: 5264373 (1993-11-01), Wang et al.
patent: 5292899 (1994-03-01), Tius et al.
patent: 5302703 (1994-04-01), Buechler et al.
patent: 5324642 (1994-06-01), Baumgartner
patent: 5325708 (1994-07-01), De Simon
patent: 5466579 (1995-11-01), Baumgartner
patent: 5532131 (1996-07-01), Lewis
patent: 5595653 (1997-01-01), Good et al.
patent: 5817766 (1998-10-01), Hui et al.
patent: 6022693 (2000-02-01), Baumgartner
patent: 6063637 (2000-05-01), Arnold et al.
patent: 6248598 (2001-06-01), Bogema
patent: 6309827 (2001-10-01), Goldstein et al.
patent: 6350582 (2002-02-01), Baumgartner
patent: 6582924 (2003-06-01), Baumgartner
patent: 6686209 (2004-02-01), Wang et al.
patent: 6702988 (2004-03-01), Sagona et al.
patent: 7465586 (2008-12-01), Day et al.
patent: 7816143 (2010-10-01), Day et al.
patent: 2002/0115089 (2002-08-01), Goldstein et al.
patent: 2002/0142484 (2002-10-01), Wang et al.
Package Insert for the AMP/MAMP/COC/OPI/THC/PCP Test for Oral Fluids, “Oral Fluid Drug Screen Device”, Oct. 4, 2003, available at www.testcountry.com/iScreenOralInsert.pdf.
Brandt, et al, J Planar Chromatography Modern TLC, (1997), 10(5):348-352 (abstract).
Chiarotti, et al, Forensic Sci Int, (2000), 114(1):1-6.
Cone, et al, J Anal Toxicol, (1987), 11(3):89-96 (abstract only).
Cone, et al, J Anal Toxicol, (2002), 26(8):541-546 (abstract only).
Gustafson, et al, J Chromatography B, (2003), 798:145-154.
Gustafson, et al, Clin Chem, (2003), 49(7):1114-1124.
Gustafson, et al, J Anal Toxicol, (2004), 28(3):160-167.
Kintz, et al, J Forensic Sci, (1995), 40(4):619-622 (abstract only).
Kintz, et al, www.icadts.org/proceedings/show.php?paper=2000-167.pdf, 2000.
Liang, et al, (2000), available at www.w.se/trat—sau/2000/Poster10.pdf.
Lindgren, et al, Psychopharmacology (Berl), (1981), 74(3):208-212.
Lyons, et al, J Anal Toxicol, (2001), 25(5):289-303 (abstract only).
Niedbala, et al, J Anal Toxicol, (2001), 25(5):289-303 (abstract only).
Notice of Allowance dated Aug. 12, 2008 in U.S. Appl. No. 10/980,372.
Peat, paper Mar. 27, 2000, available at http://www.4intercept.com/clinicals/test—results.html.
Perez-Reyes, et al, Clin Pharmacol Ther, (1983), 34(1):36-41 (abstract only).
Schramm, et al, J Anal Toxicol, (1992), 16(1):1-9.
Steinmeyer et al, J Chromatgraphy B, (2002), 772:239-248.
Stout, et al, J Anal Toxicol, (2001), 25(7):550-554.
US Notice of Allowance dated Jun. 16, 2010 in U.S. Appl. No. 12/270,782.
US Office Action dated Sep. 19, 2006 in U.S. Appl. No. 10/980,372.
US Office Action dated Oct. 30, 2007 in U.S. Appl. No. 10/980,372.
US Office Action dated Feb. 22, 2010 in related U.S. Appl. No. 12/270,782.
US Office Action dated Apr. 30, 2009 in U.S. Appl. No. 12/270,782.
Wall et al, J Clin Pharmacol, (1981), 21(8-9 Suppl):1785-189S (abstract only).
Wall, et al, Clin Pharmacol Ther, (1983), 34(3):352-363 (abstract only).
Day David
Feldman Michael S.
Kuntz David J.
Foley & Lardner LLP
LabOne, Inc.
Wallenhorst Maureen M
LandOfFree
Oral detection test for cannabinoid use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral detection test for cannabinoid use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral detection test for cannabinoid use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2719303